Deutsche Biotech Innovativ AG operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Deutsche Biotech Innovativ AG with three other
miscellaneous service companies in Europe:
sales of 1.23 million Swedish Kronor [US$130,532.22 ]
(116,000.00 Euro [US$129,032.60 ]
of which 94%
was Services), and
based in the United Kingdom
(£105,000.00 [US$138,522.30 ]
of which 100%
was Drug Discovery).